BamSEC and AlphaSense Join Forces
Learn More

Sunovion Cns Development Canada Ulc

Formerly NASDAQ: CYNA
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 20 pages Stock Option Plan, as Amended 2016 Amended and Restated Stock Option Plan Cynapsus Therapeutics Inc. (The “Corporation”) Directors, Management, Employees and Consultants Stock Option Plan Article 1 – Introduction
12/34/56
EX-4.8
from 10-Q 11 pages Supplemental Indenture
12/34/56
EX-4.7
from 10-Q 64 pages Cynapsus Therapeutics Inc. - And - Equity Financial Trust Company Warrant Indenture Dated as of April 15, 2014
12/34/56
EX-4.6
from 10-Q 11 pages Supplemental Indenture
12/34/56
EX-4.5
from 10-Q 61 pages Cynapsus Therapeutics Inc. - And - Equity Financial Trust Company Warrant Indenture Dated as of March 1, 2013
12/34/56
EX-4.4
from 10-Q 10 pages Warrant Certificate Warrants to Purchase Common Shares of Cynapsus Therapeutics Inc
12/34/56
EX-4.3
from 10-Q 10 pages Warrant Certificate Warrants to Purchase Common Shares of Cynapsus Therapeutics Inc
12/34/56
EX-4.2
from 10-Q 10 pages Article 1 - Exercise of Warrants
12/34/56
EX-4.1
from 10-Q 2 pages Indenture or similar
12/34/56
EX-4.1
from S-8 18 pages 2014 Amended and Restated Stock Option Plan Cynapsus Therapeutics Inc. (The “Corporation”) Directors, Management, Employees and Consultants Stock Option Plan Article 1 - Introduction
12/34/56
EX-4.8
from F-10/A 4 pages Form 51-102f3 Material Change Report
12/34/56
EX-4.7
from F-10 7 pages Schedule “A”
12/34/56
EX-4.6
from F-10 17 pages Cynapsus Therapeutics Inc. Condensed Interim Consolidated Financial Statements for the Three Months Ended March 31, 2015 (Expressed in Canadian Dollars) Unaudited Cynapsus Therapeutics Inc. Interim Consolidated Statements of Financial Position Unaudited
12/34/56
EX-4.5
from F-10 32 pages Independent Auditors’ Report of Registered Public Accounting Firm
12/34/56
EX-4.4
from F-10 51 pages Cynapsus Therapeutics Inc. Annual and Special Meeting of Shareholders and Management Information Circular April 3, 2015 Management Information Circular
12/34/56
EX-4.3
from F-10 18 pages Cynapsus Therapeutics Inc. Management Discussion and Analysis for the Three Months Ended March 31, 2015
12/34/56
EX-4.2
from F-10 42 pages Cynapsus Therapeutics Inc. Management Discussion and Analysis for the Year Ended December 31, 2014
12/34/56
EX-4.1
from F-10 82 pages Cynapsus Therapeutics Inc. Annual Information Form for the Fiscal Year Ended December 31, 2014 March 17, 2015
12/34/56